Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001564590-22-009644
Filing Date
2022-03-10
Accepted
2022-03-10 16:13:22
Documents
6
Effectiveness Date
2022-03-10

Document Format Files

Seq Description Document Type Size
1 S-8 achv-s8.htm S-8 271030
2 EX-5.1 achv-ex51_7.htm EX-5.1 13033
3 EX-23.2 achv-ex232_6.htm EX-23.2 2553
4 EX-99.2 achv-ex992_51.htm EX-99.2 114989
5 EX-FILING FEES achv-exfilingfees_104.htm EX-FILING FEES 61617
6 GRAPHIC g31bgf0ropgd000001.jpg GRAPHIC 11818
  Complete submission text file 0001564590-22-009644.txt   480894
Mailing Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021
Business Address 22722 29TH DR. SE SUITE 100 SEATTLE WA 98021 425-686-1500
ACHIEVE LIFE SCIENCES, INC. (Filer) CIK: 0000949858 (see all company filings)

EIN.: 954343413 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-263421 | Film No.: 22729189
SIC: 2835 In Vitro & In Vivo Diagnostic Substances